BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 843872)

  • 21. Cyproheptadine therapy in Cushing's disease and Nelson's syndrome.
    Jialal I; Pillay NL
    S Afr Med J; 1980 Mar; 57(9):305. PubMed ID: 7355345
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev YuV ; Slavnov VI; Luchitskii EV
    Neurosci Behav Physiol; 1982; 12(6):494-6. PubMed ID: 6314174
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: New drug treatment for Cushing's disease.
    Lancet; 1975 Dec; 2(7945):1135-6. PubMed ID: 53612
    [No Abstract]   [Full Text] [Related]  

  • 24. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
    Ooi TC; Twum-Barima Y
    J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cyproheptadin in the treatment of Cushing's syndrome (author's transl)].
    Matys Z; Marek J; Gregorová I
    Sb Lek; 1977 Aug; 79(7-8):226-30. PubMed ID: 905761
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of cushing's disease with cypropheptadine (author's transl)].
    Michelsen H; Contreras P; Bradford I; Rojas A
    Rev Med Chil; 1977 Jun; 105(6):380-3. PubMed ID: 331429
    [No Abstract]   [Full Text] [Related]  

  • 29. Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment.
    van Waveren Hogervorst CO; Koppeschaar HP; Zelissen PM; Lips CJ; Garcia BM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):652-5. PubMed ID: 8636284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medical treatment and Cushing's disease].
    Luton JP; Ghnassia JP; Bricaire H
    Sem Hop; 1977 Jun; 53(24):1476-9. PubMed ID: 197640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-invasive therapy of Cushing's syndrome].
    Miura K
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1627-32. PubMed ID: 7798761
    [No Abstract]   [Full Text] [Related]  

  • 36. Five cases of cyclical Cushing's syndrome.
    Atkinson AB; Kennedy AL; Carson DJ; Hadden DR; Weaver JA; Sheridan B
    Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1453-7. PubMed ID: 2998540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Cushing disease in Childhood with cyproheptadine.
    D'Ercole AJ; Morris MA; Underwood LE; Van Wyk JJ; Feldman JM
    J Pediatr; 1977 May; 90(5):834-5. PubMed ID: 853345
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Cushing's disease: a hypothalamic flush?
    Feldman JM
    N Engl J Med; 1975 Oct; 293(18):930-1. PubMed ID: 170520
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyproheptadine-induced remission of Cushing's disease.
    Krieger DT; Amorosa L; Linick F
    N Engl J Med; 1975 Oct; 293(18):893-6. PubMed ID: 1177986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on drug therapy of Cushing's syndrome].
    Winkelmann W; Fricke U; Hackenberg K; Heesen D; Hoff HG; Hummerich W; Liesen H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1337-40. PubMed ID: 347777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.